ORBIMED CAPITAL LLC - Insider Non-Derivative Transactions at Kinnate Biopharma Inc. (KNTE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 17, 2023, ORBIMED CAPITAL LLC's relationship to Kinnate Biopharma Inc. (KNTE) is Director,TenPercentOwner, and currently has 550,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KNTE insiders.
Data Source: SEC.
ORBIMED CAPITAL LLC - Insider Non-Derivative Transactions at KNTE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 18, 2023 | Acquisition -- (Common Stock) | 550000 | 0 | 550000 |